SLC5A2 and diabetes mellitus: That discrepancy may be attributed to factors such as the resetting of tubuloglomerular feedback (i.e., adjustment of its operating point) (Thomson and Blantz, 2008), or sex-specific transporter alterations in diabetes and SGLT2 inhibition that have yet to be characterized.